Dynamics in Post-pandemic Global Ketorolac Tromethamine Industry: Supply and Demand, Markets and Prices 2021-2027
Report Code: KNJ668228 No. of Pages: 160 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Ketorolac Tromethamine market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Ketorolac Tromethamine market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Injection Ophthalmic Nasal Oral tablet Segmented by End User/Segment Short-term treatment of pain Ophthalmic Surgery Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey West Ward Pharmaceuticals Teva Sun Pharmaceutical Sandoz Sagent Pharmaceuticals Pfizer Omeros Corporation Mylan Gland Pharma Limited Fresenius Kabi Egalet US Inc. Dr. Reddy’s Laboratories Aurobindo Pharma Apotex Amphastar Pharmaceuticals Allergan Akorn
Table of Contents
1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Ketorolac Tromethamine Market Status and Forecast (2016-2027)
1.3.2 Global Ketorolac Tromethamine Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Ketorolac Tromethamine Supply by Company
2.1 Global Ketorolac Tromethamine Sales Volume by Company
2.2 Global Ketorolac Tromethamine Sales Value by Company
2.3 Global Ketorolac Tromethamine Price by Company
2.4 Ketorolac Tromethamine Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Ketorolac Tromethamine Market Status by Category
3.1 Ketorolac Tromethamine Category Introduction
3.1.1 Injection
3.1.2 Ophthalmic
3.1.3 Nasal
3.1.4 Oral tablet
3.2 Global Ketorolac Tromethamine Market by Category
3.2.1 Global Ketorolac Tromethamine Sales Volume by Category (2016-2021)
3.2.2 Global Ketorolac Tromethamine Sales Value by Category (2016-2021)
3.2.3 Global Ketorolac Tromethamine Price by Category (2016-2021)
3.3 North America: by Category
3.4 Europe: by Category
3.5 Asia Pacific: by Category
3.6 Central & South America: by Category
3.7 Middle East & Africa: by Category
4 Global and Regional Ketorolac Tromethamine Market Status by End User/Segment
4.1 Ketorolac Tromethamine Segment by End User/Segment
4.1.1 Short-term treatment of pain
4.1.2 Ophthalmic Surgery
4.2 Global Ketorolac Tromethamine Market by End User/Segment
4.2.1 Global Ketorolac Tromethamine Sales Volume by End User/Segment (2016-2021)
4.2.2 Global Ketorolac Tromethamine Sales Value by End User/Segment (2016-2021)
4.2.3 Global Ketorolac Tromethamine Price by End User/Segment (2016-2021)
4.3 North America: by End User/Segment
4.4 Europe: by End User/Segment
4.5 Asia Pacific: by End User/Segment
4.6 Central & South America: by End User/Segment
4.7 Middle East & Africa: by End User/Segment
5 Global Ketorolac Tromethamine Market Status by Region
5.1 Global Ketorolac Tromethamine Market by Region
5.1.1 Global Ketorolac Tromethamine Sales Volume by Region
5.1.2 Global Ketorolac Tromethamine Sales Value by Region
5.2 North America Ketorolac Tromethamine Market Status
5.3 Europe Ketorolac Tromethamine Market Status
5.4 Asia Pacific Ketorolac Tromethamine Market Status
5.5 Central & South America Ketorolac Tromethamine Market Status
5.6 Middle East & Africa Ketorolac Tromethamine Market Status
6 North America Ketorolac Tromethamine Market Status
6.1 North America Ketorolac Tromethamine Market by Country
6.1.1 North America Ketorolac Tromethamine Sales Volume by Country (2016-2021)
6.1.2 North America Ketorolac Tromethamine Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Ketorolac Tromethamine Market Status
7.1 Europe Ketorolac Tromethamine Market by Country
7.1.1 Europe Ketorolac Tromethamine Sales Volume by Country (2016-2021)
7.1.2 Europe Ketorolac Tromethamine Sales Value by Country (2016-2021)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Ketorolac Tromethamine Market Status
8.1 Asia Pacific Ketorolac Tromethamine Market by Country
8.1.1 Asia Pacific Ketorolac Tromethamine Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific Ketorolac Tromethamine Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Ketorolac Tromethamine Market Status
9.1 Central & South America Ketorolac Tromethamine Market by Country
9.1.1 Central & South America Ketorolac Tromethamine Sales Volume by Country (2016-2021)
9.1.2 Central & South America Ketorolac Tromethamine Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Ketorolac Tromethamine Market Status
10.1 Middle East & Africa Ketorolac Tromethamine Market by Country
10.1.1 Middle East & Africa Ketorolac Tromethamine Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa Ketorolac Tromethamine Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Ketorolac Tromethamine Manufacturing Cost Analysis
11.5 Ketorolac Tromethamine Sales Channel and Distributors Analysis
11.5.1 Ketorolac Tromethamine Sales Channel
11.5.2 Ketorolac Tromethamine Distributors
11.6 Ketorolac Tromethamine Downstream Major Buyers
12 Global Ketorolac Tromethamine Market Forecast by Category and by End User/Segment
12.1 Global Ketorolac Tromethamine Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global Ketorolac Tromethamine Forecast by Category
12.2.1 Global Ketorolac Tromethamine Sales Volume Forecast by Category
12.2.2 Global Ketorolac Tromethamine Sales Value Forecast by Category
12.2.3 Global Ketorolac Tromethamine Price Forecast by Category
12.3 Global Ketorolac Tromethamine Forecast by End User/Segment
12.3.1 Global Ketorolac Tromethamine Sales Volume Forecast by End User/Segment
12.3.2 Global Ketorolac Tromethamine Sales Value Forecast by End User/Segment
12.3.3 Global Ketorolac Tromethamine Price Forecast by End User/Segment
13 Global Ketorolac Tromethamine Market Forecast by Region/Country
13.1 Global Ketorolac Tromethamine Market Forecast by Region (2022-2027)
13.1.1 Global Ketorolac Tromethamine Sales Volume Forecast by Region (2022-2027)
13.1.2 Global Ketorolac Tromethamine Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 West Ward Pharmaceuticals
14.1.1 Company Information
14.1.2 Ketorolac Tromethamine Product Introduction
14.1.3 West Ward Pharmaceuticals
Ketorolac Tromethamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.1.4 SWOT Analysis
14.2 Teva
14.2.1 Company Information
14.2.2 Ketorolac Tromethamine Product Introduction
14.2.3 Teva
Ketorolac Tromethamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.2.4 SWOT Analysis
14.3 Sun Pharmaceutical
14.3.1 Company Information
14.3.2 Ketorolac Tromethamine Product Introduction
14.3.3 Sun Pharmaceutical
Ketorolac Tromethamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.3.4 SWOT Analysis
14.4 Sandoz
14.4.1 Company Information
14.4.2 Ketorolac Tromethamine Product Introduction
14.4.3 Sandoz
Ketorolac Tromethamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.4.4 SWOT Analysis
14.5 Sagent Pharmaceuticals
14.5.1 Company Information
14.5.2 Ketorolac Tromethamine Product Introduction
14.5.3 Sagent Pharmaceuticals
Ketorolac Tromethamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.5.4 SWOT Analysis
14.6 Pfizer
14.6.1 Company Information
14.6.2 Ketorolac Tromethamine Product Introduction
14.6.3 Pfizer
Ketorolac Tromethamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.6.4 SWOT Analysis
14.7 Omeros Corporation
14.7.1 Company Information
14.7.2 Ketorolac Tromethamine Product Introduction
14.7.3 Omeros Corporation
Ketorolac Tromethamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.7.4 SWOT Analysis
14.8 Mylan
14.8.1 Company Information
14.8.2 Ketorolac Tromethamine Product Introduction
14.8.3 Mylan
Ketorolac Tromethamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.8.4 SWOT Analysis
14.9 Gland Pharma Limited
14.9.1 Company Information
14.9.2 Ketorolac Tromethamine Product Introduction
14.9.3 Gland Pharma Limited
Ketorolac Tromethamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.9.4 SWOT Analysis
14.10 Fresenius Kabi
14.10.1 Company Information
14.10.2 Ketorolac Tromethamine Product Introduction
14.10.3 Fresenius Kabi
Ketorolac Tromethamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.10.4 SWOT Analysis
14.11 Egalet US Inc.
14.12 Dr. Reddy’s Laboratories
14.13 Aurobindo Pharma
14.14 Apotex
14.15 Amphastar Pharmaceuticals
14.16 Allergan
14.17 Akorn
15 Conclusion
16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com